- Report
- August 2025
- 182 Pages
Global
From €3222EUR$3,545USD£2,779GBP
€3580EUR$3,939USD£3,088GBP
- Report
- November 2025
- 150 Pages
Global
From €4408EUR$4,850USD£3,802GBP
- Report
- February 2026
- 160 Pages
Global
From €3772EUR$4,150USD£3,253GBP
- Report
- January 2026
- 186 Pages
Global
From €3222EUR$3,545USD£2,779GBP
€3580EUR$3,939USD£3,088GBP
- Report
- January 2026
- 184 Pages
Global
From €3222EUR$3,545USD£2,779GBP
€3580EUR$3,939USD£3,088GBP
- Report
- January 2026
- 192 Pages
Global
From €3222EUR$3,545USD£2,779GBP
€3580EUR$3,939USD£3,088GBP
- Report
- November 2025
- 200 Pages
Global
From €7226EUR$7,950USD£6,232GBP
- Report
- May 2026
- 120 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- December 2025
- 150 Pages
Global
From €4408EUR$4,850USD£3,802GBP
- Report
- July 2024
- 150 Pages
Global
From €5408EUR$5,950USD£4,664GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1818EUR$2,000USD£1,568GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1136EUR$1,250USD£980GBP
- Report
- April 2026
- 211 Pages
Australia
From €4408EUR$4,850USD£3,802GBP
- Report
- April 2026
- 215 Pages
India
From €4408EUR$4,850USD£3,802GBP
- Report
- April 2026
- 219 Pages
Malaysia
From €4408EUR$4,850USD£3,802GBP
- Report
- April 2026
- 222 Pages
China
From €4408EUR$4,850USD£3,802GBP
- Report
- April 2026
- 226 Pages
Spain
From €4408EUR$4,850USD£3,802GBP
- Report
- October 2023
- 129 Pages
Global
From €3500EUR$4,125USD£3,124GBP
- Report
- June 2025
- 210 Pages
Global
From €4090EUR$4,500USD£3,527GBP
- Report
- September 2021
- 40 Pages
China
From €2363EUR$2,600USD£2,038GBP

Coagulants are a type of hematological drug used to treat and prevent excessive bleeding. They work by helping the body form clots to stop bleeding. Coagulants are used to treat a variety of conditions, including hemophilia, deep vein thrombosis, and pulmonary embolism. They are also used to prevent excessive bleeding during surgery and childbirth. Coagulants are available in both oral and injectable forms.
The coagulant market is a rapidly growing segment of the hematological drug market. It is driven by the increasing prevalence of bleeding disorders, the growing demand for safer and more effective treatments, and the development of new drugs. The market is expected to continue to grow in the coming years, driven by the increasing demand for coagulants and the development of new drugs.
Some of the major companies in the coagulant market include Bayer AG, Pfizer Inc., Novo Nordisk A/S, Sanofi S.A., and CSL Behring. Show Less Read more